Alexandria Real Estate Equities, INC

Market Movers (8-K)

See all →
NYSE
Alexandria Real Estate Equities, Inc. has amended its credit agreement, securing a $5 billion revolving credit facility with an option to increase by $1 billion and extending its maturity to 2032.
NYSE
Alexandria Real Estate Equities, Inc. has issued $1 billion in 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057, guaranteed by Alexandria Real Estate Equities, L.P.
Capital raise
NYSE
Alexandria Real Estate Equities, Inc. has priced a $1 billion offering of 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057.
Capital raise
NYSE
Alexandria Real Estate Equities, Inc. announced its second quarter 2026 financial and operating results, showcasing solid leasing activity and a strengthened balance sheet.
NYSE
Alexandria Real Estate Equities, Inc. has entered into an escrow agreement for a new $5 billion credit facility, expected to become effective by October 1, 2026.
NYSE
Alexandria Real Estate Equities reported Q1 2026 diluted FFO per share of $1.73 and net income per share of $2.10, while maintaining a strong balance sheet and executing on its capital recycling strategy.

Quarterly Earnings (10-Q)

See all →
NYSE
Alexandria Real Estate Equities reported a significant drop in net income and FFO for Q1 2026, primarily due to increased vacancy and asset dispositions.
Worse than expected
Capital raise
NYSE
Alexandria Real Estate Equities, Inc. reported a significant net loss for the nine months ended September 30, 2025, driven by substantial real estate impairments and a challenging life science market.
Worse than expected
Capital raise
Delay expected
NYSE
Alexandria Real Estate Equities, a leading life science REIT, reported a net loss for the second quarter and first half of 2025, driven by significant real estate and investment impairments, despite strong leasing activity and cost control measures.
Worse than expected
Capital raise
Delay expected
NYSE
Alexandria Real Estate Equities reports a net loss for Q1 2025 and adjusts its full-year guidance, citing slower leasing and increased interest expenses.
Worse than expected
NYSE
Alexandria Real Estate Equities reports a strong third quarter in 2024, marked by solid leasing activity and strategic dispositions, while navigating a complex macroeconomic environment.
Capital raise
NYSE
Alexandria Real Estate Equities reports a net income of $42.9 million for the second quarter of 2024, alongside strategic portfolio adjustments and continued leasing activity.
Worse than expected
Capital raise

Annual Reports (10-K)

NYSE
Alexandria Real Estate Equities, Inc. reported a net loss of $1.44 billion for 2025, a significant decline from 2024, driven by substantial real estate impairments and a dividend reduction, amidst challenging life science market conditions.
Worse than expected
Delay expected
Capital raise
NYSE
Alexandria Real Estate Equities demonstrates resilience with strong leasing activity and strategic capital management in its 2024 annual report.
Worse than expected
Delay expected
Capital raise
NYSE
Alexandria Real Estate Equities outlines its stock structure, dividend policy, and corporate governance practices in its latest 10-K filing.

Insider Trading (Form 4)

See all →
NYSE
Hallie E. Kuhn, EVP - Cap Market & Co-Lead -LS of Alexandria Real Estate Equities, Inc., reported a transaction in 914 shares of common stock on September 15, 2026.
NYSE
Bret E. Gossett, EVP - Co-RMD of Alexandria Real Estate Equities, Inc., reported a transaction in 584 shares of common stock on September 15, 2026.
NYSE
Gregory Calvin Thomas, EVP - CTO of Alexandria Real Estate Equities, Inc., reported a transaction in 1,096 shares of common stock on September 15, 2026.
NYSE
Blake L. Stevens, Regional Market Director of Alexandria Real Estate Equities, Inc., reported a transaction in 471 shares of common stock on September 15, 2026.
NYSE
Jenna R. Foger, EVP - Co-Lead - Life Science of Alexandria Real Estate Equities, Inc., reported a transaction in 1,086 shares of common stock on September 15, 2026.
NYSE
Michael E. Boss, Co-Regional Market Director of Alexandria Real Estate Equities, Inc., reported a transaction in 1,462 shares of common stock on September 15, 2026.

Proxy Statements (Def-14A)

NYSE
Alexandria Real Estate Equities details a challenging 2025, outlining strategic resets, governance enhancements, and executive compensation adjustments in its latest proxy statement.
Worse than expected
Capital raise
Delay expected
NYSE
Alexandria Real Estate Equities, Inc. has filed a definitive proxy statement with the SEC.
NYSE
Alexandria Real Estate Equities is asking stockholders to approve an amended and restated stock award and incentive plan to enhance its ability to attract and retain key personnel.
NYSE
Alexandria Real Estate Equities is asking stockholders to approve an amendment and restatement of its 1997 Stock Award and Incentive Plan at the upcoming annual meeting.

Schedule 13G - Passive Investments

NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 8% in Alexandria Real Estate Equities Inc., holding over 13.8 million shares.
NYSE
The Vanguard Group reports zero beneficial ownership in Alexandria Real Estate Equities Inc. following an internal realignment.
NYSE
Alexandria Real Estate Equities and its subsidiaries have updated their beneficial ownership in Applied Therapeutics, Inc., reporting a combined stake primarily through warrants.